Humoral Immunity Profiling of Subjects with Myalgic Encephalomyelitis Using a Random Peptide Microarray Differentiates Cases from Controls with High Specificity and Sensitivity

[1]  I. Mena,et al.  Myalgic encephalomyelitis: International Consensus Criteria , 2011, Journal of internal medicine.

[2]  A. Carvalho,et al.  The Role of Microbiota and Intestinal Permeability in the Pathophysiology of Autoimmune and Neuroimmune Processes with an Emphasis on Inflammatory Bowel Disease Type 1 Diabetes and Chronic Fatigue Syndrome. , 2016, Current pharmaceutical design.

[3]  Kazumi Fujiwara,et al.  A potential biomarker for fatigue: Oxidative stress and anti-oxidative activity , 2016, Biological Psychology.

[4]  S. Carding,et al.  A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)? , 2016, Journal of clinical medicine.

[5]  A. Palotás,et al.  Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome , 2016, Translational Psychiatry.

[6]  D. P. Lewis,et al.  Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study☆ , 2015, Sleep science.

[7]  Dragan Maric,et al.  Human endogenous retrovirus-K contributes to motor neuron disease , 2015, Science Translational Medicine.

[8]  M. Rajeevan,et al.  Pathway-focused genetic evaluation of immune and inflammation related genes with chronic fatigue syndrome. , 2015, Human immunology.

[9]  S. Johnston,et al.  Immunosignature: Serum Antibody Profiling for Cancer Diagnostics. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[10]  A. Rizvanov,et al.  Cytokine expression provides clues to the pathophysiology of Gulf War illness and myalgic encephalomyelitis. , 2015, Cytokine.

[11]  Mehdi Farhoudi,et al.  Amyloid-Beta: A Crucial Factor in Alzheimer's Disease , 2014, Medical Principles and Practice.

[12]  P. Stafford,et al.  Epitope Identification from Fixed-complexity Random-sequence Peptide Microarrays , 2014, Molecular & Cellular Proteomics.

[13]  Phillip Stafford,et al.  Scalable high-density peptide arrays for comprehensive health monitoring , 2014, Nature Communications.

[14]  P. Stafford,et al.  Application of Immunosignatures for Diagnosis of Valley Fever , 2014, Clinical and Vaccine Immunology.

[15]  M. Clerici,et al.  Multiple sclerosis-associated retrovirus and related human endogenous retrovirus-W in patients with multiple sclerosis , 2014, Journal of Neuroimmunology.

[16]  Gordon Broderick,et al.  A Role for Homeostatic Drive in the Perpetuation of Complex Chronic Illness: Gulf War Illness and Chronic Fatigue Syndrome , 2014, PloS one.

[17]  D. Coomans,et al.  High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients. , 2013, Anaerobe.

[18]  M. Fletcher,et al.  A comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome , 2013, BMC Immunology.

[19]  J. Montoya,et al.  Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology , 2013, Journal of Translational Medicine.

[20]  A. Palotás,et al.  Plasmacytoid dendritic cells in the duodenum of individuals diagnosed with myalgic encephalomyelitis are uniquely immunoreactive to antibodies to human endogenous retroviral proteins. , 2013, In vivo.

[21]  Phillip Stafford,et al.  Feasibility of an early Alzheimer's disease immunosignature diagnostic test , 2013, Journal of Neuroimmunology.

[22]  T. Hausken,et al.  Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome , 2012, BMC Infectious Diseases.

[23]  J. Newton,et al.  Impaired blood pressure variability in chronic fatigue syndrome--a potential biomarker. , 2012, QJM : monthly journal of the Association of Physicians.

[24]  Gordon Broderick,et al.  Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue , 2012, Journal of Translational Medicine.

[25]  S. Kiani-Alikhan,et al.  Chronic fatigue syndrome, the immune system and viral infection , 2012, Brain, Behavior, and Immunity.

[26]  Ø. Fluge,et al.  Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study , 2011, PloS one.

[27]  Phillip Stafford,et al.  Application of immunosignatures to the assessment of Alzheimer's disease , 2011, Annals of neurology.

[28]  L. Cannon-Albright,et al.  Evidence for a heritable predisposition to Chronic Fatigue Syndrome , 2011, BMC neurology.

[29]  A. Rademaker,et al.  CFS prevalence and risk factors over time , 2011, Journal of health psychology.

[30]  M. Antoni,et al.  Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome , 2010, Behavioral and Brain Functions.

[31]  Gordon Broderick,et al.  A formal analysis of cytokine networks in Chronic Fatigue Syndrome , 2010, Brain, Behavior, and Immunity.

[32]  F. Togo,et al.  Cytokines across the Night in Chronic Fatigue Syndrome with and without Fibromyalgia , 2010, Clinical and Vaccine Immunology.

[33]  Mary Ann Fletcher,et al.  Plasma cytokines in women with chronic fatigue syndrome , 2009, Journal of Translational Medicine.

[34]  J. Deijen,et al.  Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series , 2009, BMC neurology.

[35]  M. Ban,et al.  HERV-K113 is not associated with multiple sclerosis in a large family-based study. , 2008, AIDS research and human retroviruses.

[36]  N. Klimas,et al.  Chronic fatigue syndrome: Inflammation, immune function, and neuroendocrine interactions , 2007, Current rheumatology reports.

[37]  M. Maes,et al.  Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. , 2007, Journal of affective disorders.

[38]  B. Huber,et al.  Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis. , 2005, The Journal of rheumatology.

[39]  James F. Jones,et al.  Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome , 2004, Journal of Molecular Medicine.

[40]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[41]  D. Tyrrell,et al.  Cytokines in parvovirus b19 infection as an aid to understanding chronic fatigue syndrome , 2003, Current pain and headache reports.

[42]  T. Takano,et al.  Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. , 2003, International journal of molecular medicine.

[43]  Elizabeth R. Unger,et al.  Utility of the Blood for Gene Expression Profiling and Biomarker Discovery in Chronic Fatigue Syndrome , 2003, Disease markers.

[44]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[45]  P. Sullivan,et al.  A Twin Study of Chronic Fatigue , 2001, Psychosomatic medicine.

[46]  J. Vecchiet,et al.  Chronic fatigue syndrome following a toxic exposure. , 2001, The Science of the total environment.

[47]  R. Patarca,et al.  Cytokines and Chronic Fatigue Syndrome , 2001, Annals of the New York Academy of Sciences.

[48]  J. Thompson,et al.  Multiple sequence alignment with Clustal X. , 1998, Trends in biochemical sciences.

[49]  D. Buchwald,et al.  Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. , 1996, The Journal of clinical investigation.

[50]  R. Poljak,et al.  Thermodynamics of antigen-antibody binding using specific anti-lysozyme antibodies. , 1995, European journal of biochemistry.

[51]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[52]  L. Prasad,et al.  Evaluation of mutagenesis for epitope mapping. Structure of an antibody-protein antigen complex. , 1994, The Journal of biological chemistry.

[53]  M. Fletcher,et al.  Evidence for T-helper 2 shift and association with illness parameters in chronic fatigue syndrome (CFS). , 2008, Bulletin of the IACFS/ME.

[54]  R. Wheatland.  Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression. , 2005, Medical hypotheses.

[55]  R. Yolken,et al.  HERV-W-related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder , 2004, Molecular Psychiatry.

[56]  P. Flor-Henry,et al.  Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols , 2003 .

[57]  Inger Sandlie,et al.  Therapeutic antibodies for human diseases at the dawn of the twenty-first century , 2003, Nature Reviews Drug Discovery.

[58]  N. McGregor,et al.  Chronic Fatigue Syndrome Guidelines , 2003 .

[59]  D. Bell,et al.  Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases. , 1991, Reviews of infectious diseases.